Journal
ALLERGOLOGIA ET IMMUNOPATHOLOGIA
Volume 40, Issue 5, Pages 281-287Publisher
ELSEVIER DOYMA SL
DOI: 10.1016/j.aller.2011.05.016
Keywords
Rhinitis; IgE level; Eosinophil count; Bayes' theorem; Atopy
Categories
Funding
- GlaxoSmithKline
- Schering AG
- Novartis
Ask authors/readers for more resources
Background: To use probability theory to establish threshold values for total serum IgE and eosinophil counts that support a diagnosis of allergic rhinitis and to compare our results with previously published data. Methods: Prospective study of rhinitis patients using a modified version of Bayes' theorem. Study included 125 patients at the West Los Angeles VA Medical Center diagnosed with rhinitis who completed allergy consultation and immediate hypersensitivity skin testing. Results: Eighty-nine of 125 patients were atopic by prick and/or intradermal skin testing. Using a modified version of Bayes' theorem and positive and negative probability weights, calculations for different thresholds of serum IgE and eosinophil counts were summated and a posttest probability for atopy was calculated. Calculated posttest probabilities varied according to the threshold used to determine a positive or negative test; however, IgE thresholds greater than 140 IU/ml and eosinophil counts greater that 80 cells/ml were found to have a high probability of predicting atopy in patients with rhinitis. Moreover, had a greater influence than eosinophil count in determining posttest probability of allergy in this population. Considerable differences were noted in the IgE levels of atopic and non-atopic patients, including those with asthma or a history of smoking. However, these differences were not observed with eosinophil levels. Conclusions: Using a modified version of Bayes' theorem to determine posttest probability, IgE threshold levels greater than 140 IU/ml and eosinophil counts greater than 80 cells/ml in an individual with clinical signs and symptoms of rhinitis are likely to correlate with an atopic aetiology. This model of probability may be helpful in evaluating individuals for diagnostic skin testing and certain types of allergy-modifying treatment. (c) 2011 SEICAP. Published by Elsevier Espana, S.L. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available